Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Platelet mitophagy is a major pathway involved in the clearance of injured mitochondria during hemostasis and thrombosis. Prohibitin 2 (PHB2) has recently emerged as an inner mitochondrial membrane receptor involved in mitophagy. However, the mechanisms underlying PHB2‑mediated platelet mitophagy and activation are not completely understood. PHB2 is a highly conserved inner mitochondrial membrane protein that regulates mitochondrial assembly and function due to its unique localization on the mitochondrial membrane. The present study aimed to investigate the role and mechanism underlying PHB2 in platelet mitophagy and activation. Phorbol‑12‑myristate‑13‑acetate (PMA) was used to induce MEG‑01 cells maturation and differentiate into platelets following PHB2 knockdown. Cell Counting Kit‑8 assays were performed to examine platelet viability. Flow cytometry was performed to assess platelet mitochondrial membrane potential. RT‑qPCR and western blotting were conducted to measure mRNA and protein expression levels, respectively. Subsequently, platelets were exposed to CCCP and the role of PHB2 was assessed. The results of the present study identified a crucial role for PHB2 in platelet mitophagy and activation, suggesting that PHB2‑mediated regulation of mitophagy may serve as a novel strategy for downregulating the expression of platelet activation genes. Although further research into mitophagy is required, the present study suggested that PHB2 may serve as a novel therapeutic target for thrombosis‑related diseases due to its unique localization on the mitochondrial membrane.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986013PMC
http://dx.doi.org/10.3892/mmr.2021.12023DOI Listing

Publication Analysis

Top Keywords

platelet mitophagy
20
mitochondrial membrane
20
mitophagy activation
16
mechanisms underlying
8
platelet
8
mitophagy
8
inner mitochondrial
8
unique localization
8
localization mitochondrial
8
phb2 platelet
8

Similar Publications

Thrombopoietin (TPO), a principal hematopoietic cytokine, regulates the development and proliferation of megakaryocytes and platelets. Our previous research demonstrated TPO's neuroprotective role against hypoxic-ischemic brain injury in rats. Yet, the underlying mechanisms remain unclear.

View Article and Find Full Text PDF

DUT (p.Y116C)-Mutation-Induced Thrombocytopenia in Rabbits.

Int J Mol Sci

April 2025

State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, and College of Veterinary Medicine, Jilin University, Changchun 130062, China.

Thrombocytopenia is a hematologic disorder characterized by an abnormally low platelet count in peripheral blood. Recent studies have identified mutations in DUT as the primary cause of bone marrow failure and diabetes mellitus syndrome (BMFDMS), a condition commonly associated with thrombocytopenia. In this study, a novel rabbit model of thrombocytopenia carrying the DUT c.

View Article and Find Full Text PDF

Though abnormal platelet function is detected in Huntington's disease (HD), thrombin's role is indistinct. Through protease-activated receptor 1 (PAR-1) activation, thrombin triggers intricate pathways relevant to HD. Therefore, we propose that posttreatment with the PAR-1 inhibitor SCH79797 may alleviate symptoms in a 3-nitropropionic acid (3-NP) HD model.

View Article and Find Full Text PDF

Mitochondrial dysfunction in Parkinson's disease.

J Neural Transm (Vienna)

December 2024

Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo, Tokyo, 113-8421, Japan.

Article Synopsis
  • The exact cause of nigral cell death in Parkinson's disease (PD) is still unclear, but research has made significant progress using models like MPTP-induced experimental parkinsonism, highlighting mitochondrial failure as a key factor in cell death.
  • Many studies have linked mitochondrial dysfunction to PD, observing deficiencies in mitochondrial complexes (specifically Complex I and III) in various tissues of PD patients, though there’s some debate on its impact in peripheral organs.
  • Mutations in mitochondrial DNA and involvement of specific genes related to mitochondrial quality control (like parkin and PINK1) further suggest that mitochondrial issues play a crucial role in the pathophysiology of PD.
View Article and Find Full Text PDF

Background: Type 2 diabetes mellitus (T2DM) presents a thrombotic environment, contributing to diabetic macroangiopathy and microangiopathy. In this study, the regulation of microthrombosis in T2DM was assessed.

Methods: Platelets from T2DM patients and healthy controls were analyzed using 4D label-free proteomics and bioinformatics.

View Article and Find Full Text PDF